Starting January 1, 2026, health insurance policies sold in South Dakota must cover biomarker testing (blood, tissue, or other specimen analysis that identifies disease markers) when a doctor orders it for diagnosis, treatment, or monitoring of a patient's condition, as long as the testing is supported by medical evidence. The requirement applies to both individual and group health insurance policies, though it excludes limited-benefit plans like disease-specific coverage.
Commerce and Energy Deferred to the 41st legislative day Passed, YEAS 13, NAYS 0.
Commerce and Energy Motion to amend
Commerce and Energy Scheduled for hearing
First read in House and referred to House Commerce and Energy H.J. 133
Prime sponsor · Rep
R
Dist. HD-005
Cosponsors
Commerce and Energy — Deferred to the 41st legislative day